$30.28+0.24 (+0.80%)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Smith & Nephew plc in the Healthcare sector is trading at $30.28 with a market capitalization of $12.7B. Wall Street consensus targets $34.99 (5 analysts), implying a +15.6% move over the next 12 months. The stock is currently near its 52-week low of $29.08, remaining 8.3% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Me...
Is SNN a good stock to buy? We came across a bullish thesis on Smith & Nephew plc on r/ValueInvesting by Senior_Tadpole_3913. In this article, we will summarize the bulls’ thesis on SNN. Smith & Nephew plc’s share was trading at $29.61 as of June 23rd. SNN’s trailing and forward P/E were 20.52 and 13.26 respectively according […]
European equities traded in the US as American depositary receipts were lower late Wednesday morning
European equities traded in the US as American depositary receipts started the week higher late Mond
European equities traded in the US as American depositary receipts were trending higher late Friday
Activists also report to the SEC on Groupo Aeroportuario del Sureste, Constellium, Satellogic, and Oorvo.